Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology
Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.


GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by massaadmon Nov 16, 2000 6:31pm
219 Views
Post# 2841728

RE: Stock Day/Alliance

RE: Stock Day/AllianceMr Day made a fool of himself both in the english and french debate, until further notice he is a second choice. JC who had a lot to lose held his ground, thats some sort of a defensive victory. The future is foggy as it is now, wouldnt like to be voting for a hidden agenda, no thanks! Tho i have to admit i would have preferred martin leading the way! anyways enuff politics, hope conac comes out with a B2B (back 2 back) news releases, one about financials and one bout the LOI! this is what'll take to break that .35c! would hate to see a pop and back where we started, the wait this time will be longer... long on cot.. Mike
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities